Orient EuroPharma Co., Ltd. (4120.TWO)

TWD 44.5

(0.0%)

EBITDA Summary of Orient EuroPharma Co., Ltd.

  • Orient EuroPharma Co., Ltd.'s latest annual EBITDA in 2023 was 582.93 Million TWD , up 996.84% from previous year.
  • Orient EuroPharma Co., Ltd.'s latest quarterly EBITDA in 2024 Q2 was 61.37 Million TWD , up 163.07% from previous quarter.
  • Orient EuroPharma Co., Ltd. reported an annual EBITDA of -34.14 Million TWD in 2022, down -148.52% from previous year.
  • Orient EuroPharma Co., Ltd. reported an annual EBITDA of 133.32 Million TWD in 2021, down -72.29% from previous year.
  • Orient EuroPharma Co., Ltd. reported a quarterly EBITDA of 35.05 Million TWD for 2024 Q1, down -95.66% from previous quarter.
  • Orient EuroPharma Co., Ltd. reported a quarterly EBITDA of 524.96 Million TWD for 2023 Q4, up 865.93% from previous quarter.

Annual EBITDA Chart of Orient EuroPharma Co., Ltd. (2023 - 2019)

Historical Annual EBITDA of Orient EuroPharma Co., Ltd. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 582.93 Million TWD 996.84%
2022 -34.14 Million TWD -148.52%
2021 133.32 Million TWD -72.29%
2020 493.8 Million TWD -0.62%
2019 484.03 Million TWD 0.0%

Peer EBITDA Comparison of Orient EuroPharma Co., Ltd.

Name EBITDA EBITDA Difference
Allied Biotech Corporation 204.79 Million TWD -184.648%
GeneFerm Biotechnology Co., Ltd. 231.09 Million TWD -152.251%
Easywell Biomedicals, Inc. -85.5 Million TWD 781.79%
TTY Biopharm Company Limited 1.52 Billion TWD 61.759%
Synmosa Biopharma Corporation 1 Billion TWD 42.211%
Center Laboratories, Inc. -175.17 Million TWD 432.784%
Tien Liang BioTech Co., Ltd. 31.04 Million TWD -1777.535%
Orient Pharma Co., Ltd. 172.39 Million TWD -238.14%
InnoPharmax Inc. -62.12 Million TWD 1038.405%
Johnson Chemical Pharmaceutical Works Co., Ltd. 126.67 Million TWD -360.172%
Excelsior Biopharma Inc. -29.36 Million TWD 2084.872%
DV Biomed Co., Ltd. 407.64 Million TWD -43.003%
Foresee Pharmaceuticals Co., Ltd. -912.16 Million TWD 163.907%
Handa Pharmaceuticals, Inc. 802.78 Million TWD 27.386%
UniPharma Co., Ltd. -16.25 Million TWD 3686.422%
Anxo Pharmaceutical Co., Ltd. 131.31 Million TWD -343.94%
Alar Pharmaceuticals Inc. 394.52 Million TWD -47.759%
Winston Medical Supply Co., Ltd. 228.32 Million TWD -155.31%
Mercury Biopharmaceutical Corporation -39.03 Million TWD 1593.408%
Bioray Biotech Co., Ltd 12.13 Million TWD -4703.766%
TSH Biopharm Corporation Limited 99.35 Million TWD -486.751%